By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Telix Pharmaceuticals Limited 

55 Flemington Road
Suite 226
North Melbourne    VIC 3051  Australia
Phone: n/a Fax: n/a


SEARCH JOBS

Telix Pharmaceuticals Limited is a new Australian (unlisted) public company that has been established to develop and commercialize several late-stage oncology assets. Our specialty area is “theranostic” radiopharmaceuticals – agents that are able to simultaneously image and treat cancer patients.

We are currently in “stealth mode” as we are currently closing several transactions. Please come back and check on us again soon. Feel free to contact us at info@telixpharma.com.

YEAR FOUNDED:

2015

LEADERSHIP:

CEO: Dr. Christian Behrenbruch


Key Statistics


Email: info@telixpharma.com.
Ownership: Private

Web Site: Telix Pharma
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
Telix Pharma And Cellsight Technologies Conclude Collaboration And License Agreement For VisAcT ImmunoPET Technology 9/20/2017 8:23:53 AM
Telix Pharma And Cellsight Technologies Conclude Collaboration And License Agreement For VisAcT ImmunoPET Technology 9/20/2017 8:23:53 AM
Kevin McCann And Mark Nelson Appointed To The Board Of Directors Of Telix Pharma 9/18/2017 8:13:09 AM
Cyclotek And Telix Pharma Conclude Radiopharmaceutical Manufacturing Agreement For Australia And New Zealand 7/31/2017 12:02:32 PM
Abzena And Telix Pharma Sign License Agreement For Abzena’s Prostate-Specific Membrane Antigen Antibodies 7/18/2017 7:36:53 AM
Telix Pharma, ATLAB Pharma Release: Companies Conclude Therapeutic Product Development Agreement For Prostate Cancer 1/19/2017 7:13:43 AM
Telix Pharma Release: Company Acquires Glioblastoma Program From Therapeia GmbH & Co. KG 1/19/2017 7:12:08 AM
Wilex AG (WL6.DE) Release: Company Signs Antibody License Agreement With Telix Pharma 1/16/2017 8:58:58 AM
//-->